Pharmaceutical company AstraZeneca announced a $50 billion investment in the United States by 2030 that includes a “drug substance facility” in Virginia that will be the company’s largest single manufacturing investment in the world. The company added that additional funds will go towards the company’s existing or planned facilities in California, Indiana, Maryland, Massachusetts, and Texas.
